Several species of mycobacteria are characterized as atypical because they differ in certain aspects from the prototype, M. tuberculosis. For example, atypical mycobacteria are wide spread in the environment and are not pathogenic for guinea pigs, whereas M. tuberculosis is found only in humans and is highly pathogenic for guinea pigs. The atypical mycobacteria are sometimes called mycobacteria other than tuberculosis (MOTT) or non-tuberculous mycobacteria (NTM).
The atypical mycobacteria are classified into four groups according to their rate of growth and whether they produce pigment under certain conditions (Table 1). The atypical mycobacteria in groups I, II, and III grow slowly, at a rate similar to that of M. tuberculosis, whereas those in group IV are “rapid growers,” producing colonies in fewer than 7 days. Group I organisms produce a yellow-orange–pigmented colony only when exposed to light (photochromogens), whereas group II organisms produce the pigment chiefly in the dark (scotochromogens). Group III mycobacteria produce little or no yellow-orange pigment, irrespective of the presence or absence of light (nonchromogens). A summary of the clinical features of the important atypical mycobacteria is presented in Table 2.

Table1. Runyon’s Classification of Atypical Mycobacteria

Table2. Clinical Features of Atypical Mycobacteria
Group I (Photochromogens)
M. kansasii causes lung disease clinically resembling tuberculosis. Because it is antigenically similar to M. tuberculosis, patients are frequently tuberculin skin test positive. Its habitat in the environment is unknown, but infections by this organism are localized to the midwestern states and Texas. It is susceptible to the standard antituberculosis drugs.
Mycobacterium marinum causes “swimming pool granuloma,” also known as “fish tank granuloma.” These granulomatous, ulcerating lesions occur in the skin at the site of abrasions incurred at swimming pools and aquariums. The natural habitat of the organism is both fresh and salt water. Treatment with a tetracycline such as minocycline is effective.
Group II (Scotochromogens)
M. scrofulaceum causes scrofula, a granulomatous cervical adenitis, usually in children. (M. tuberculosis also causes scrofula.) The organism enters through the oropharynx and infects the draining lymph nodes. Its natural habitat is environmental water sources, but it has also been isolated as a saprophyte from the human respiratory tract. Scrofula caused by M. scrofulaceum can often be cured by surgical excision of the affected lymph nodes.
Group III (Nonchromogens)
Mycobacterium avium-intracellulare complex (MAI, MAC) is composed of two species, M. avium and M. intracellulare, that are very difficult to distinguish from each other by standard laboratory tests. They cause pulmonary disease clinically indistinguishable from tuberculosis, primarily in immunocompromised patients such as those with AIDS who have CD4 cell counts of less than 200/μL. MAC is the most common bacterial cause of disease in AIDS patients. The organisms are widespread in the environment, including water and soil, particularly in the southeastern United States. MAC is much less communicable from person to person than is M. tuberculosis. They are highly resistant to antituberculosis drugs, and as many as six drugs in combination are frequently required for adequate treatment. Current drugs of choice are azithromycin or clarithromycin plus one or more of the following: ethambutol, rifabutin, or ciprofloxacin. Azithromycin is currently recommended for pre venting disease in AIDS patients.
Mycobacterium ulcerans causes necrotizing skin lesions that progress to ulcerated lesions (Buruli ulcer). It is a common pathogen in tropical, rural, and wetland areas. Transmission is related to skin trauma plus exposure to contaminated water. Children are often affected. The organism grows preferentially at 30°C rather than 37°C. Treatment involves at least 8 weeks of a combination of rifampin and clarithromycin. Surgical debridement of the lesions may be useful.
Group IV (Rapidly Growing Mycobacteria)
Mycobacterium fortuitum-chelonae complex is composed of two similar species, M. fortuitum and M. chelonae. They are saprophytes, found chiefly in soil and water, and rarely cause human disease. Infections occur chiefly in two populations: (1) immunocompromised patients and (2) individuals with prosthetic hip joints and indwelling catheters. Skin and soft tissue infections occur at the site of puncture wounds (e.g., at tattoo sites). They are often resistant to antituberculosis therapy, and therapy with multiple drugs in combination plus surgical excision may be required for effective treatment. Current drugs of choice are amikacin plus doxycycline.
Mycobacterium abscessus is another rapidly growing mycobacteria acquired from the environment. It causes chronic lung infections, especially in cystic fibrosis patients, as well as infections of the skin, bone, and joints. It is highly antibiotic resistant. Current drugs of choice are amikacin plus imipenem or cefoxitin plus clarithromycin.
Mycobacterium smegmatis is a rapidly growing mycobacterium that is not associated with human disease. It is part of the normal flora of smegma, the material that collects under the foreskin of the penis.